期刊文献+

右美托咪定对神经病理性疼痛大鼠脊髓P2X4R蛋白表达的影响

EFFECTS OF DEXMEDETOMIDINE ON P2X4R PROTEIN EXPRESSION IN SPINAL CORD OF NEUROPATHIC PAIN RATS
下载PDF
导出
摘要 目的:观察右美托咪定对神经病理性痛大鼠脊髓P2X4R总蛋白及膜蛋白表达水平的影响。方法:雄性SD大鼠40只,180~220 g,随机分为4组(每组10只):正常组(N组)、假手术组(S组)、神经病理性痛组(SNI组)、右美托咪定组(Dex组)。N组不作任何处理,Dex组于术后即刻腹腔注射右美托咪定40μg/kg,间隔24 h追加给药一次至术后14 d,S组和SNI组均腹腔注射等容量的生理盐水。术前1 d及术后1、3、5、7、14 d检测机械缩足反射阈值(MWT)。术后14 d用Western blot方法检测脊髓L4~6节段P2X4R总蛋白和膜蛋白表达量。结果:与N组和S组相比,SNI组大鼠术后MWT明显降低(P〈0.05),脊髓水平P2X4R总蛋白和膜蛋白表达量均明显增加(P〈0.05);与SNI组相比,Dex组MWT明显升高(P〈0.05),脊髓水平P2X4R总蛋白和膜蛋白表达量均明显降低(P〈0.05)。结论:Dex能减轻大鼠神经病理性痛,其机制可能与抑制脊髓P2X4R总蛋白及膜蛋白水平有关。 Objective: To investigate effects of dexmedetomidine on neuropathic pain ( NP ) and expression of P2X4R protein in the spinal cord in rats with NP. Methods: Forty male SD rats weighing 180 - 220 g were randomly divided into 4 groups ( n = 10 in each group ) , they were naive ( N ) , sham-operated (S), neuropathic pain ( SNI ) and dexmedetomidine-treated groups ( Dex ) respectively. N group rats received no treatment. In Dex group, Dexmedetomidine ( 40 lag/kg) was injected intraperitionally daily for 14 days starting immediately after surgery. S and SNI groups rats were injected saline as control. The mechanical paw withdrawal threshold ( MWT ) were measured before surgery and on postoperative day 1, 3, 5, 7 and 14. The L4-6 segment of spinal cords were used to determinate the level of P2X4R total protein and membrane protein by Western blot on day 14. Results: MWT were significantly decreased (P 〈 0.05) and the level of expression of P2X4R total protein and membrane protein increased significantly in the spinal cord in SNI rats, compared with those in N group and S group ( P 〈 0.05 ) . Compared with SNI group, MWT were significantly increased and the expression of P2X4R total protein and membrane protein were significantly down-regulated after operation in Dex group ( P 〈 0.05 ) . Conclusion: Dexmedetomidine can reduce neuropathic pain in rats with SNI and its underlying mechanism may be involved in inhibition of expression of P2X4R.
出处 《中国疼痛医学杂志》 CAS CSCD 2015年第4期255-258,共4页 Chinese Journal of Pain Medicine
基金 国家自然科学基金青年基金项目(81200861) 江苏省教育厅"青蓝工程"资助(53041212) 徐州市科技计划项目(KC14SH075)
关键词 右美托咪定 神经病理性疼痛 脊髓 P2X4R 膜蛋白 Dexmedetomidine Neuropathic pain Spinal cord P2X4R Membrane protein
  • 相关文献

参考文献15

  • 1王萍,田玉科.神经病理性疼痛脊髓机制的研究进展[J].中国疼痛医学杂志,2009,15(1):47-49. 被引量:11
  • 2黄露露,于世英.神经病理性疼痛的中枢敏化发病机制[J].中国疼痛医学杂志,2011,17(8):463-465. 被引量:29
  • 3Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424:778 - 783.
  • 4Li SS, Zhang WS, Ji D. Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI. Neurosci Lett, 2014, 560:21 - 25.
  • 5Liu L, Ji F, Liang J, et al. Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury. Brain Res, 2012, 1427:1 - 9.
  • 6Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain, 2000, 87:149 - 158.
  • 7Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods, 1994, 53:55 - 63.
  • 8Bumstock G. Purinergic P2 receptors as targets for novelanalgesics. Pharmacol Ther, 2006, 110:433 - 454.
  • 9Hanani M. Intercellular communication in sensory ganglia by purinergic receptors and gap junctions: implications for chronic pain. Brain Res, 2012, 1487:183 - 191.
  • 10Hasaka M, Mori T, Matsuura T, et al. Effects of general anesthetics on P2X4 receptors in a mouse microglial cell line. Neuroreport, 2012, 23:601 - 605.

二级参考文献16

  • 1Ruscheweyh R, Forsthuber L, Schoffnegger D, et al. Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adeha-, and C-fibers after chronic constriction injury in mice. J Comp Neurol,2007,502 : 325 336.
  • 2Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol, 2006,17 : 592 - 604.
  • 3Velazquez KT, Mohammad H, Sweitzer SM. Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res, 2007,55 : 578 -589.
  • 4Prescott SA, Sejnowski TJ, De Koninck Y. Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain. Mol Pain, 2006,2 : 32.
  • 5Scholz J, Broom DC, Youn DH, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci, 2005,25 : 7317 -7323.
  • 6Przewlocki R, Przewlockal B. Opioids in neuropathic pain. Curr Pharm,2005,11 : 3013 - 3025.
  • 7Xu M, Petraschka M, McLaughlin JP, et al. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci, 2004,24 : 4576 4584.
  • 8Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev, 2008,32:972-983.
  • 9Schafers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Rev Neurother, 2007,7 : 1613 - 1627.
  • 10Bee LA, Dickenson AH. Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience, 2007,147 : 786 - 793.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部